Page last updated: 2024-10-22

arecoline and Clinically Isolated CNS Demyelinating Syndrome

arecoline has been researched along with Clinically Isolated CNS Demyelinating Syndrome in 1 studies

Arecoline: An alkaloid obtained from the betel nut (Areca catechu), fruit of a palm tree. It is an agonist at both muscarinic and nicotinic acetylcholine receptors. It is used in the form of various salts as a ganglionic stimulant, a parasympathomimetic, and a vermifuge, especially in veterinary practice. It has been used as a euphoriant in the Pacific Islands.
arecoline : A tetrahydropyridine that is 1,2,5,6-tetrahydropyridine with a methyl group at position 1, and a methoxycarbonyl group at position 3. An alkaloid found in the areca nut, it acts as an agonist of muscarinic acetylcholine.

Research Excerpts

ExcerptRelevanceReference
"Cerebral demyelination is possibly one of the main pathological factors involved in the development of schizophrenia."5.51Arecoline attenuates memory impairment and demyelination in a cuprizone-induced mouse model of schizophrenia. ( Adilijiang, A; He, J; Li, X; Lin, D; Wang, W; Xu, Z; You, P, 2019)
"Cerebral demyelination is possibly one of the main pathological factors involved in the development of schizophrenia."1.51Arecoline attenuates memory impairment and demyelination in a cuprizone-induced mouse model of schizophrenia. ( Adilijiang, A; He, J; Li, X; Lin, D; Wang, W; Xu, Z; You, P, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Xu, Z1
Adilijiang, A1
Wang, W1
You, P1
Lin, D1
Li, X1
He, J1

Other Studies

1 other study available for arecoline and Clinically Isolated CNS Demyelinating Syndrome

ArticleYear
Arecoline attenuates memory impairment and demyelination in a cuprizone-induced mouse model of schizophrenia.
    Neuroreport, 2019, 01-16, Volume: 30, Issue:2

    Topics: Animals; Arecoline; Chelating Agents; Cholinergic Agonists; Cuprizone; Demyelinating Diseases; Disea

2019